NETO2 and gastric cancer: NETO2 enhanced the invasive ability of GC cells in vitro and metastatic capability in vivo by inducing epithelial–mesenchymal transition (EMT) through upregulating TNFRSF12A to activate PI3K/AKT/NF-κB/Snail axis.